Maharashtra government upholds FDA decision to cancel J&J’s India licence
The Maharashtra government has announced it’s upholding the FDA’s decision to cancel Johnson & Johnson India’s licence to manufacture products from its Mulund facility, following complaints of carcinogenic substances residue in its talcum powder.